Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cytomegalovirus disease (CMV) is a viral infection that can affect one part of the body, such as the eyes, or it can spread throughout the body.
The report details the trend, potential and market size of Cytomegalovirus Disease Treatments market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cytomegalovirus Disease Treatmentsmarket, defines the market attractiveness level of Cytomegalovirus Disease Treatments market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cytomegalovirus Disease Treatments industry, describes the types of Cytomegalovirus Disease Treatments market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cytomegalovirus Disease Treatments market and the development prospects and opportunities of Cytomegalovirus Disease Treatments industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cytomegalovirus Disease Treatments market in Chapter 13.
By Player:
Cell Medical Ltd
Abbott Laboratories, Inc
GlaxoSmithKline plc
Merck & Co Inc
Affymetrix, Inc
ViroPharma
AiCuris Anti-infective Cures GmbH
F Hoffmann-La Roche Ltd
Chimerix, Inc
Johnson & Johnson
Shire plc Becton
Dickinson and Company
Bio-Rad Laboratories, Inc
By Type:
Ganciclovir
Valganciclovir
Foscarnet
Cidofovir
Others
By End-User:
Stem Cell Transplantation
Organ Transplantation
Congenital CMV Infection
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cytomegalovirus Disease Treatments Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cytomegalovirus Disease Treatments Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cytomegalovirus Disease Treatments Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cytomegalovirus Disease Treatments Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cytomegalovirus Disease Treatments Market Analysis and Outlook to 2022
-
7.1 Global Cytomegalovirus Disease Treatments Consumption (2017-2022)
-
7.2 United States Cytomegalovirus Disease Treatments Consumption (2017-2022)
-
7.3 Europe Cytomegalovirus Disease Treatments Consumption (2017-2022)
-
7.4 China Cytomegalovirus Disease Treatments Consumption (2017-2022)
-
7.5 Japan Cytomegalovirus Disease Treatments Consumption (2017-2022)
-
7.6 India Cytomegalovirus Disease Treatments Consumption (2017-2022)
-
7.7 South Korea Cytomegalovirus Disease Treatments Consumption (2017-2022)
8 Region and Country-wise Cytomegalovirus Disease Treatments Market Analysis and Outlook to 2028
-
8.1 Global Cytomegalovirus Disease Treatments Consumption Forecast (2022-2028)
-
8.2 United States Cytomegalovirus Disease Treatments Consumption Forecast (2022-2028)
-
8.3 Europe Cytomegalovirus Disease Treatments Consumption Forecast (2022-2028)
-
8.4 China Cytomegalovirus Disease Treatments Consumption Forecast (2022-2028)
-
8.5 Japan Cytomegalovirus Disease Treatments Consumption Forecast (2022-2028)
-
8.6 India Cytomegalovirus Disease Treatments Consumption Forecast (2022-2028)
-
8.7 South Korea Cytomegalovirus Disease Treatments Consumption Forecast (2022-2028)
9 Global Cytomegalovirus Disease Treatments Market Outlook by Types and Applications to 2022
-
9.1 Global Cytomegalovirus Disease Treatments Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Ganciclovir Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Valganciclovir Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Foscarnet Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Cidofovir Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Cytomegalovirus Disease Treatments Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Stem Cell Transplantation Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Organ Transplantation Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Congenital CMV Infection Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Cytomegalovirus Disease Treatments Market Outlook by Types and Applications to 2028
-
10.1 Global Cytomegalovirus Disease Treatments Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Ganciclovir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Valganciclovir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Foscarnet Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Cidofovir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cytomegalovirus Disease Treatments Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Stem Cell Transplantation Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Organ Transplantation Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Congenital CMV Infection Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Cytomegalovirus Disease Treatments Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cytomegalovirus Disease Treatments Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cytomegalovirus Disease Treatments Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cytomegalovirus Disease Treatments Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cytomegalovirus Disease Treatments Market Competitive Analysis
-
14.1 Cell Medical Ltd
-
14.1.1 Cell Medical Ltd Company Details
-
14.1.2 Cell Medical Ltd Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Cell Medical Ltd Cytomegalovirus Disease Treatments Product and Service
-
14.2 Abbott Laboratories, Inc
-
14.2.1 Abbott Laboratories, Inc Company Details
-
14.2.2 Abbott Laboratories, Inc Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Abbott Laboratories, Inc Cytomegalovirus Disease Treatments Product and Service
-
14.3 GlaxoSmithKline plc
-
14.3.1 GlaxoSmithKline plc Company Details
-
14.3.2 GlaxoSmithKline plc Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline plc Cytomegalovirus Disease Treatments Product and Service
-
14.4 Merck & Co Inc
-
14.4.1 Merck & Co Inc Company Details
-
14.4.2 Merck & Co Inc Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck & Co Inc Cytomegalovirus Disease Treatments Product and Service
-
14.5 Affymetrix, Inc
-
14.5.1 Affymetrix, Inc Company Details
-
14.5.2 Affymetrix, Inc Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Affymetrix, Inc Cytomegalovirus Disease Treatments Product and Service
-
14.6 ViroPharma
-
14.6.1 ViroPharma Company Details
-
14.6.2 ViroPharma Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 ViroPharma Cytomegalovirus Disease Treatments Product and Service
-
14.7 AiCuris Anti-infective Cures GmbH
-
14.7.1 AiCuris Anti-infective Cures GmbH Company Details
-
14.7.2 AiCuris Anti-infective Cures GmbH Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AiCuris Anti-infective Cures GmbH Cytomegalovirus Disease Treatments Product and Service
-
14.8 F Hoffmann-La Roche Ltd
-
14.8.1 F Hoffmann-La Roche Ltd Company Details
-
14.8.2 F Hoffmann-La Roche Ltd Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 F Hoffmann-La Roche Ltd Cytomegalovirus Disease Treatments Product and Service
-
14.9 Chimerix, Inc
-
14.9.1 Chimerix, Inc Company Details
-
14.9.2 Chimerix, Inc Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Chimerix, Inc Cytomegalovirus Disease Treatments Product and Service
-
14.10 Johnson & Johnson
-
14.10.1 Johnson & Johnson Company Details
-
14.10.2 Johnson & Johnson Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Johnson & Johnson Cytomegalovirus Disease Treatments Product and Service
-
14.11 Shire plc Becton
-
14.11.1 Shire plc Becton Company Details
-
14.11.2 Shire plc Becton Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Shire plc Becton Cytomegalovirus Disease Treatments Product and Service
-
14.12 Dickinson and Company
-
14.12.1 Dickinson and Company Company Details
-
14.12.2 Dickinson and Company Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Dickinson and Company Cytomegalovirus Disease Treatments Product and Service
-
14.13 Bio-Rad Laboratories, Inc
-
14.13.1 Bio-Rad Laboratories, Inc Company Details
-
14.13.2 Bio-Rad Laboratories, Inc Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Bio-Rad Laboratories, Inc Cytomegalovirus Disease Treatments Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cytomegalovirus Disease Treatments
-
Figure Cytomegalovirus Disease Treatments Picture
-
Table Global Cytomegalovirus Disease Treatments Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cytomegalovirus Disease Treatments Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cytomegalovirus Disease Treatments Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cytomegalovirus Disease Treatments Consumption by Country (2017-2022)
-
Figure United States Cytomegalovirus Disease Treatments Consumption and Growth Rate (2017-2022)
-
Table Europe Cytomegalovirus Disease Treatments Consumption and Growth Rate (2017-2022)
-
Figure China Cytomegalovirus Disease Treatments Consumption and Growth Rate (2017-2022)
-
Figure Japan Cytomegalovirus Disease Treatments Consumption and Growth Rate (2017-2022)
-
Figure India Cytomegalovirus Disease Treatments Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cytomegalovirus Disease Treatments Consumption and Growth Rate (2017-2022)
-
Figure Global Cytomegalovirus Disease Treatments Consumption Forecast by Country (2022-2028)
-
Figure United States Cytomegalovirus Disease Treatments Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cytomegalovirus Disease Treatments Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cytomegalovirus Disease Treatments Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cytomegalovirus Disease Treatments Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cytomegalovirus Disease Treatments Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cytomegalovirus Disease Treatments Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ganciclovir Consumption and Growth Rate (2017-2022)
-
Figure Global Valganciclovir Consumption and Growth Rate (2017-2022)
-
Figure Global Foscarnet Consumption and Growth Rate (2017-2022)
-
Figure Global Cidofovir Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Stem Cell Transplantation Consumption and Growth Rate (2017-2022)
-
Figure Global Organ Transplantation Consumption and Growth Rate (2017-2022)
-
Figure Global Congenital CMV Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Ganciclovir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Valganciclovir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Foscarnet Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cidofovir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stem Cell Transplantation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Organ Transplantation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Congenital CMV Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cytomegalovirus Disease Treatments Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cytomegalovirus Disease Treatments Export by Region (Top 5 Countries) (2017-2028)
-
Table Cell Medical Ltd (Foundation Year, Company Profile and etc.)
-
Table Cell Medical Ltd Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cell Medical Ltd Cytomegalovirus Disease Treatments Product and Service
-
Table Abbott Laboratories, Inc (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories, Inc Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories, Inc Cytomegalovirus Disease Treatments Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Cytomegalovirus Disease Treatments Product and Service
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Cytomegalovirus Disease Treatments Product and Service
-
Table Affymetrix, Inc (Foundation Year, Company Profile and etc.)
-
Table Affymetrix, Inc Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Affymetrix, Inc Cytomegalovirus Disease Treatments Product and Service
-
Table ViroPharma (Foundation Year, Company Profile and etc.)
-
Table ViroPharma Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
Table ViroPharma Cytomegalovirus Disease Treatments Product and Service
-
Table AiCuris Anti-infective Cures GmbH (Foundation Year, Company Profile and etc.)
-
Table AiCuris Anti-infective Cures GmbH Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
Table AiCuris Anti-infective Cures GmbH Cytomegalovirus Disease Treatments Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Cytomegalovirus Disease Treatments Product and Service
-
Table Chimerix, Inc (Foundation Year, Company Profile and etc.)
-
Table Chimerix, Inc Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chimerix, Inc Cytomegalovirus Disease Treatments Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Cytomegalovirus Disease Treatments Product and Service
-
Table Shire plc Becton (Foundation Year, Company Profile and etc.)
-
Table Shire plc Becton Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire plc Becton Cytomegalovirus Disease Treatments Product and Service
-
Table Dickinson and Company (Foundation Year, Company Profile and etc.)
-
Table Dickinson and Company Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dickinson and Company Cytomegalovirus Disease Treatments Product and Service
-
Table Bio-Rad Laboratories, Inc (Foundation Year, Company Profile and etc.)
-
Table Bio-Rad Laboratories, Inc Cytomegalovirus Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Rad Laboratories, Inc Cytomegalovirus Disease Treatments Product and Service
-
